Management of Mucocutaneous Herpes Simplex Virus Infections

Drugs

Volumn 27, Issue 4, 1984, Pages 364-372

  Straus, Stephen E ^a   Seidlin, Mindell ^a   Takiff, Howard ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR;

DRUG THERAPY; FEMALE GENITAL SYSTEM; GENITAL HERPES; HERPES LABIALIS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE GENITAL SYSTEM; ORAL DRUG ADMINISTRATION; REVIEW; THERAPY; TOPICAL DRUG ADMINISTRATION; VIRUS INFECTION;

ACYCLOVIR; DIAGNOSIS, DIFFERENTIAL; FEMALE; HERPES GENITALIS; HERPES LABIALIS; HUMAN; MALE; PATIENT EDUCATION;

EID: 0021323273     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/00003495-198427040-00004     Document Type: Article

References (7)

1. The course of untreated recurrent genital herpes simplex infection in 27 women
2. Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes
3. Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response
4. Acyclovir: A review of its pharmacodynamic properties and therapeutic efficacy
5. The natural history of recurrent herpes simplex labialis. Implications for antiviral therapy
6. Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation
7. The natural history of herpes simplex virus infection of mother and newborn